|
|
||||||||
Although GH is known to regulate somatic growth during development, its role in regulating adult body composition is less well defined. The effects of GH on individual body compartments – water, fat, protein and mineral – are achieved both by the action of GH and by a GH-induced hormone, insulin-like growth factor-I (IGF-I). We used a genetic model of GH deficiency, the 'little' (gene symbol lit) mouse, to determine the GH regulation of IGF-I and its insulin-like growth factor-binding proteins (IGFBPs) and to define the interaction between these hormones and each body compartment in adults.
Our results showed that GH-deficient lit/lit mice had reduced levels of serum IGF-I (range 38–130 µg/l) compared with normal lit/+ littermates (range 432–567 µg/l) between 2 and 52 weeks of age. The lit/lit mice did not experience the fivefold increase in IGF-I between 2 and 4 weeks of age that was seen in lit/+ mice. In lit/lit serum, overall binding of 125I-labelled IGF-I to the four IGFBPs was reduced, solely in response to a reduced amount of IGFBP-3. No overall differences were found between lit/lit and lit/+ mice in the binding of 125I-labelled IGF-I to IGFBP-2, -1 or -4. Age-related declines in IGF-I and IGFBPs were seen in lit/lit mice. However, adult levels of IGF-I were maintained in lit/+ mice to at least 52 weeks of age, as were levels of IGFBP-1 and -4, while IGFBP-3 and -2 declined with age.
With respect to body composition, comparison of lit/lit with lit/+ mice showed that the lit/lit mice were characterized by abnormally large adipose tissue stores and reduced body water, protein and mineral from 2 weeks onward. These changes occurred despite normal energy intake in lit/lit mice up to 52 weeks of age, indicating that neither undernutrition nor hyperphagia is characteristic of this GH-induced model of obesity. Furthermore, lit/lit males accrued more body fat beginning at an earlier age than lit/lit females. With advancing age, the per cent body fat increased in both lit/lit and lit/+ mice, while the per cent body water and mineral declined. In lit/lit but not lit/+ mice, per cent protein also declined with age. The changes in body water and fat are attributable to lack of adequate GH in the genetically GH-deficient lit/lit mouse. On the other hand, the changes in body protein are more likely to be effects of IGF-I. Changes in mineral observed in lit/lit mice could be the result of action by GH, IGF-I or both hormones. Therefore, when GH is chronically manipulated by GH deficiency as in lit/lit mice, by GH excess as in acromegaly, or by GH therapy, all four body compartments are affected, suggesting that GH therapy is most valuable when the treatment goal is to alter overall body composition.
Journal of Endocrinology (1993) 136, 91–104
This article has been cited by other articles:
![]() |
J. M. Mercader, J. J. Lozano, L. Sumoy, M. Dierssen, J. Visa, M. Gratacos, and X. Estivill Hypothalamus transcriptome profile suggests an anorexia-cachexia syndrome in the anx/anx mouse model Physiol Genomics, November 1, 2008; 35(3): 341 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Eleswarapu, Z. Gu, and H. Jiang Growth Hormone Regulation of Insulin-Like Growth Factor-I Gene Expression May Be Mediated by Multiple Distal Signal Transducer and Activator of Transcription 5 Binding Sites Endocrinology, May 1, 2008; 149(5): 2230 - 2240. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Reddy, D. Amador-Noguez, G. J. Darlington, B. A. Scholz, L. H. Michael, C. J. Hartley, M. L. Entman, and G. E. Taffet Cardiac Function in Young and Old Little Mice J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2007; 62(12): 1319 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. del Rincon, K. Iida, B. D. Gaylinn, C. E. McCurdy, J. W. Leitner, L. A. Barbour, J. J. Kopchick, J. E. Friedman, B. Draznin, and M. O. Thorner Growth Hormone Regulation of p85{alpha} Expression and Phosphoinositide 3-Kinase Activity in Adipose Tissue: Mechanism for Growth Hormone-Mediated Insulin Resistance Diabetes, June 1, 2007; 56(6): 1638 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Davies, E. F. Gevers, A. E. Stevenson, K. T. Coschigano, M. M. El-Kasti, M. J. Bull, C. Elford, B. A. J. Evans, J. J. Kopchick, and T. Wells Adiposity profile in the dwarf rat: an unusually lean model of profound growth hormone deficiency Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1483 - E1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Govoni, S. K. Lee, R. B. Chadwick, H. Yu, Y. Kasukawa, D. J. Baylink, and S. Mohan Whole genome microarray analysis of growth hormone-induced gene expression in bone: T-box3, a novel transcription factor, regulates osteoblast proliferation Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E128 - E136. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fleenor, J. Oden, P. A. Kelly, S. Mohan, S. Alliouachene, M. Pende, S. Wentz, J. Kerr, and M. Freemark Roles of the Lactogens and Somatogens in Perinatal and Postnatal Metabolism and Growth: Studies of a Novel Mouse Model Combining Lactogen Resistance and Growth Hormone Deficiency Endocrinology, January 1, 2005; 146(1): 103 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iida, E. Itoh, D.-S. Kim, J. P del Rincon, K. T Coschigano, J. J Kopchick, and M. O Thorner Muscle mechano growth factor is preferentially induced by growth hormone in growth hormone-deficient lit/lit mice J. Physiol., October 15, 2004; 560(2): 341 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bouillon, E. Koledova, O. Bezlepkina, J. Nijs, E. Shavrikhova, E. Nagaeva, O. Chikulaeva, V. Peterkova, I. Dedov, A. Bakulin, et al. Bone Status and Fracture Prevalence in Russian Adults with Childhood-Onset Growth Hormone Deficiency J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4993 - 4998. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alba and R. Salvatori A Mouse with Targeted Ablation of the Growth Hormone-Releasing Hormone Gene: A New Model of Isolated Growth Hormone Deficiency Endocrinology, September 1, 2004; 145(9): 4134 - 4143. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iida, J. P. del Rincon, D.-S. Kim, E. Itoh, K. T. Coschigano, J. J. Kopchick, and M. O. Thorner Regulation of full-length and truncated growth hormone (GH) receptor by GH in tissues of lit/lit or bovine GH transgenic mice Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E566 - E573. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Chandrashekar, D. Zaczek, and A. Bartke The Consequences of Altered Somatotropic System on Reproduction Biol Reprod, July 1, 2004; 71(1): 17 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
Genetically Modified Animals in Endocrinology Endocr. Rev., June 1, 2004; 25(3): 512 - 519. [Full Text] [PDF] |
||||
![]() |
R. K. Bains, S. E. Wells, D. M. Flavell, K. M. Fairhall, M. Strom, P. Le Tissier, and I. C. A. F. Robinson Visceral Obesity without Insulin Resistance in Late-Onset Obesity Rats Endocrinology, June 1, 2004; 145(6): 2666 - 2679. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. E. Meyer, D. Korthaus, W. Jagla, E. Cornali, J. Grosse, H. Fuchs, M. Klingenspor, S. Roemheld, M. Tschop, G. Heldmaier, et al. A Novel Missense Mutation in the Mouse Growth Hormone Gene Causes Semidominant Dwarfism, Hyperghrelinemia, and Obesity Endocrinology, May 1, 2004; 145(5): 2531 - 2541. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iida, J. P. Del Rincon, D.-S. Kim, E. Itoh, R. Nass, K. T. Coschigano, J. J. Kopchick, and M. O. Thorner Tissue-Specific Regulation of Growth Hormone (GH) Receptor and Insulin-Like Growth Factor-I Gene Expression in the Pituitary and Liver of GH-Deficient (lit/lit) Mice and Transgenic Mice that Overexpress Bovine GH (bGH) or a bGH Antagonist Endocrinology, April 1, 2004; 145(4): 1564 - 1570. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tronche, C. Opherk, R. Moriggl, C. Kellendonk, A. Reimann, L. Schwake, H. M. Reichardt, K. Stangl, D. Gau, A. Hoeflich, et al. Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth Genes & Dev., March 1, 2004; 18(5): 492 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kasukawa, D. J. Baylink, J. E. Wergedal, Y. Amaar, A. K. Srivastava, R. Guo, and S. Mohan Lack of Insulin-Like Growth Factor I Exaggerates the Effect of Calcium Deficiency on Bone Accretion in Mice Endocrinology, November 1, 2003; 144(11): 4682 - 4689. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Coschigano, A. N. Holland, M. E. Riders, E. O. List, A. Flyvbjerg, and J. J. Kopchick Deletion, But Not Antagonism, of the Mouse Growth Hormone Receptor Results in Severely Decreased Body Weights, Insulin, and Insulin-Like Growth Factor I Levels and Increased Life Span Endocrinology, September 1, 2003; 144(9): 3799 - 3810. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kasukawa, D. J. Baylink, R. Guo, and S. Mohan Evidence that Sensitivity to Growth Hormone (GH) Is Growth Period and Tissue Type Dependent: Studies in GH-Deficient lit/lit Mice Endocrinology, September 1, 2003; 144(9): 3950 - 3957. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mohan, G. Masinde, X. Li, and D. J. Baylink Mapping Quantitative Trait Loci That Influence Serum Insulin-Like Growth Factor Binding Protein-5 Levels in F2 Mice (MRL/MpJ X SJL/J) Endocrinology, August 1, 2003; 144(8): 3491 - 3496. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Maheshwari, R. Bouillon, J. Nijs, V. S. Oganov, A. V. Bakulin, and G. Baumann The Impact of Congenital, Severe, Untreated Growth Hormone (GH) Deficiency on Bone Size and Density in Young Adults: Insights from Genetic GH-Releasing Hormone Receptor Deficiency J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2614 - 2618. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mohan, C. Richman, R. Guo, Y. Amaar, L. R. Donahue, J. Wergedal, and D. J. Baylink Insulin-Like Growth Factor Regulates Peak Bone Mineral Density in Mice by Both Growth Hormone-Dependent and -Independent Mechanisms Endocrinology, March 1, 2003; 144(3): 929 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ajo, L. Cacicedo, C. Navarro, and F. Sanchez-Franco Growth Hormone Action on Proliferation and Differentiation of Cerebral Cortical Cells from Fetal Rat Endocrinology, March 1, 2003; 144(3): 1086 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Miller, Y. Chang, A. T. Galecki, K. Al-Regaiey, J. J. Kopchick, and A. Bartke Gene Expression Patterns in Calorically Restricted Mice: Partial Overlap with Long-Lived Mutant Mice Mol. Endocrinol., November 1, 2002; 16(11): 2657 - 2666. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. De Benedetti, C. Meazza, M. Oliveri, P. Pignatti, M. Vivarelli, T. Alonzi, E. Fattori, S. Garrone, A. Barreca, and A. Martini Effect of IL-6 on IGF Binding Protein-3: A Study in IL-6 Transgenic Mice and in Patients with Systemic Juvenile Idiopathic Arthritis Endocrinology, November 1, 2001; 142(11): 4818 - 4826. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Bugni, T. M. Poole, and N. R. Drinkwater The little mutation suppresses DEN-induced hepatocarcinogenesis in mice and abrogates genetic and hormonal modulation of susceptibility Carcinogenesis, November 1, 2001; 22(11): 1853 - 1862. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bartke, K. Coschigano, J. Kopchick, V. Chandrashekar, J. Mattison, B. Kinney, and S. Hauck Genes That Prolong Life: Relationships of Growth Hormone and Growth to Aging and Life Span J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2001; 56(8): B340 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Liu, S. Yakar, and D. LeRoith Mice Deficient in Liver Production of Insulin-Like Growth Factor I Display Sexual Dimorphism in Growth Hormone-Stimulated Postnatal Growth Endocrinology, December 1, 2000; 141(12): 4436 - 4441. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Coschigano, D. Clemmons, L. L. Bellush, and J. J. Kopchick Assessment of Growth Parameters and Life Span of GHR/BP Gene-Disrupted Mice Endocrinology, July 1, 2000; 141(7): 2608 - 2613. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dorshkind and N. D. Horseman The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor Deficiency Endocr. Rev., June 1, 2000; 21(3): 292 - 312. [Abstract] [Full Text] |
||||
![]() |
J.-L. Liu and D. LeRoith Insulin-Like Growth Factor I Is Essential for Postnatal Growth in Response to Growth Hormone Endocrinology, November 1, 1999; 140(11): 5178 - 5184. [Abstract] [Full Text] |
||||
![]() |
H. C. HATCHER, N. M. WRIGHT, J. CHAO, L. CHAO, and J.-X. MA Kallikrein-binding protein is induced by growth hormone in the dwarf rat FASEB J, October 1, 1999; 13(13): 1839 - 1844. [Abstract] [Full Text] |
||||
![]() |
Y. Zhou, B. C. Xu, H. G. Maheshwari, L. He, M. Reed, M. Lozykowski, S. Okada, L. Cataldo, K. Coschigamo, T. E. Wagner, et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse) PNAS, November 25, 1997; 94(24): 13215 - 13220. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Maheshwari, S. S. Pezzoli, A. Rahim, S. M. Shalet, M. O. Thorner, and G. Baumann Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E943 - E951. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |